BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
32195 results:

  • 1. Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT.
    Rosar F; Burgard C; David S; Marlowe RJ; Bartholomä M; Maus S; Petto S; Khreish F; Schaefer-Schuler A; Ezziddin S
    Sci Rep; 2024 May; 14(1):11271. PubMed ID: 38760451
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Incretin-based drugs decrease the incidence of prostate cancer in type 2 diabetics: A pooling-up analysis.
    Lin Y; Xu G; Li L; Xiang J; Zhai L
    Medicine (Baltimore); 2024 May; 103(20):e38018. PubMed ID: 38758855
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development and Validation of a Multimodality Model Based on Whole-Slide Imaging and Biparametric MRI for Predicting Postoperative Biochemical Recurrence in prostate cancer.
    Hu C; Qiao X; Huang R; Hu C; Bao J; Wang X
    Radiol Imaging Cancer; 2024 May; 6(3):e230143. PubMed ID: 38758079
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
    Baudewyns A; Guenzel K; Halinski A; Dariane C; Delavar G; Anract J; Barry Delongchamps N; Jabbour T; Bourgeno HA; Lefebvre Y; Ferriero M; Simone G; Fourcade A; Fournier G; Oderda M; Gontero P; Bernal-Gomez A; Mastrorosa A; Roche JB; Zahr RA; Ploussard G; Fiard G; Rysankova K; Bui AP; Taha F; Windisch O; Benamran D; Vlahopoulos L; Assenmacher G; Roumeguère T; Peltier A; Diamand R
    World J Urol; 2024 May; 42(1):322. PubMed ID: 38747982
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
    Ullah A; Jiao W; Shen B
    Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A bicentric retrospective study of the correlation of EAU BCR risk groups with
    Poterszman N; Merlin C; Margail C; Ouvrard E; Imperiale A; Somme F
    Sci Rep; 2024 May; 14(1):10908. PubMed ID: 38740809
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Digital Adoption by an Organization Supporting Informal Caregivers During COVID-19 Pandemic Showing Impact on Service Use, Organizational Performance, and Carers' Well-Being: Retrospective Population-Based Database Study With Embedded User Survey.
    Szczepura A; Khan AJ; Wild D; Nelson S; Woodhouse S; Collinson M
    JMIR Aging; 2024 May; 7():e46414. PubMed ID: 38739915
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on cancer Cell Lines.
    Albani M; Fassi EMA; Moretti RM; Garofalo M; Montagnani Marelli M; Roda G; Sgrignani J; Cavalli A; Grazioso G
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731842
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from prostate cancer Patients.
    Roumeliotou A; Strati A; Chamchougia F; Xagara A; Tserpeli V; Smilkou S; Lagopodi E; Christopoulou A; Kontopodis E; Drositis I; Androulakis N; Georgoulias V; Koinis F; Kotsakis A; Lianidou E; Kallergi G
    Cells; 2024 May; 13(9):. PubMed ID: 38727318
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Vikil
    Tettey CO; Essuman EK; Aninagyei E; Kwansa-Bentum HT; Agyemang Boakye A; Kortei NK; Boamah D
    Integr Cancer Ther; 2024; 23():15347354241253846. PubMed ID: 38721848
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Associations between knowledge of health issues and health care satisfaction and propensity to complain: a cross-sectional survey of adult men in Denmark.
    Birkeland S; Bismark M; Barry MJ; Möller S
    BMJ Open; 2024 May; 14(5):e076257. PubMed ID: 38719305
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Faster both in operative time and functional recovery by the extraperitoneal daVinci SP-based robot-assisted radical prostatectomy: a propensity score matching analysis compared to transperitoneal multiport counterpart.
    Ko YH; Jang JY; Kim YU; Kim SW
    J Robot Surg; 2024 May; 18(1):205. PubMed ID: 38714543
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of COVID-19 on the time to counseling and treatment of prostate cancer.
    Filipas DK; Pose RM; Marks P; Tennstedt P; Beyer B; Tilki D; Isbarn H; Maurer T; Ludwig TA; Heinzer H; Steuber T
    Aging Male; 2024 Dec; 27(1):2347465. PubMed ID: 38712892
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of quantitative whole body PET parameters on [
    Ayati N; McIntosh L; Buteau J; Alipour R; Pudis M; Daw N; Jackson P; Hofman MS
    Cancer Imaging; 2024 May; 24(1):57. PubMed ID: 38711135
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study.
    Duwe G; Schmitteckert M; Haack M; Sparwasser P; Dotzauer R; Thomas A; Tsaur I; Brandt MP; Kurosch M; Mager R; Haferkamp A; Boehm K; Höfner T
    World J Urol; 2024 May; 42(1):297. PubMed ID: 38709326
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Synthesis, characterisation and in vitro anticancer activity of conjugated protease inhibitor-silver nanoparticles (AgNPs-PI) against human breast MCF-7 and prostate PC-3 cancer cell lines.
    Marathe K; Naik J; Maheshwari V
    Bioprocess Biosyst Eng; 2024 Jun; 47(6):931-942. PubMed ID: 38709274
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The effect of a fermented soy beverage among patients with localized prostate cancer prior to radical prostatectomy.
    Lokeshwar SD; Ali A; Weiss TR; Reynolds J; Shuch BM; Ferencz T; Kyriakides TC; Mehal WZ; Brito J; Renzulli J; Leapman MS
    BMC Urol; 2024 May; 24(1):102. PubMed ID: 38702664
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center.
    Jahnen M; Hausler T; Meissner VH; Ankerst DP; Kattan MW; Sauter A; Gschwend JE; Herkommer K
    World J Urol; 2024 May; 42(1):290. PubMed ID: 38702557
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. On the necessity of specialized knowledge-based models for SBRT prostate treatments plans.
    Scaggion A; Cavinato S; Dusi F; El Khouzai B; Guida F; Paronetto C; Rossato MA; Sapignoli S; Scott ASA; Sepulcri M; Paiusco M
    Phys Med; 2024 May; 121():103364. PubMed ID: 38701626
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1610.